News Agency
Men's Weekly

The Results of Phase II Clinical Study of KN046 Plus Chemotherapy as First-line Treatment for Metastatic NSCLC were Published in Cell Reports Medicine

  • Written by PR Newswire

SUZHOU, China, March 22, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the phase II clinical research results of anti- PD-L1/CTLA-4 bispecific antibody KN046 plus chemotherapy as first-line treatment for metastatic non-small cell lung cancer (NSCLC) were published online in the renowned journal Cell Reports Medicine (I...

Read more: The Results of Phase II Clinical Study of KN046 Plus Chemotherapy as First-line Treatment for...

Why Choosing The Right Packaging Supplies Impacts Your Business Growth

In today’s competitive market, packaging is more than just a protective layer; it is a critical part of how businesses operate and present themselves. This is where packaging supplies Melbourne become essential, providing businesses with the tools needed to protect... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion